Current Influenza Trends in the U.S. (2026)

December 25, 2025

CURRENT INFLUENZA TRENDS – United States

As of early January 2026, the United States is navigating a challenging and rapidly accelerating influenza season. Driven by a highly mutated “super flu” variant, the current data reflects a sharp mid-winter surge that is placing significant pressure on the healthcare system.

Below is a comprehensive three-part report detailing the current trends, the severity of illness, and updated prevention strategies.

Current Trends & Virologic Surveillance 🔬

The 2025–2026 season is characterized by a “vertical” increase in cases following the holiday period. Unlike the slower start of the previous year, this season is currently defined by the rapid spread of a specific subtype of Influenza A(H3N2). 📈

1. The Dominance of “Subclade K”

The primary driver of this season’s intensity is a new H3N2 variant known as subclade K (scientifically classified as J.2.4.1). 🧬

• Genetic Drift: This variant contains seven key mutations in its hemagglutinin surface proteins that were not present in the strains used to develop this year’s vaccine.

• Prevalence: In recent laboratory characterizations, subclade K accounted for 89.5% of all subtyped H3N2 samples.

• Viral Dynamics: Public health labs report that 94.7% of all positive specimens are Influenza A, with H3N2 representing over 91% of subtyped cases.

2. National Activity Levels 🗺️

As of Week 51 (ending late December 2025), influenza activity is high or very high in 32 jurisdictions.

• Test Positivity: Clinical lab positivity has surged to 25.6% nationally. ⚠️

• Hotspots: Region 8 (Mountain states like Colorado and Utah) reports the highest positivity at 34.9%, while the Southeastern U.S. remains a close second.

• Outpatient Surge: Visits for Influenza-Like Illness (ILI) currently sit at 6.0%, nearly double the national baseline of 3.1%. 🏥

Morbidity & Mortality Analysis 📊

The 2025–2026 season is tracking toward a higher-than-average burden, with hospitalization rates reaching levels not seen since the 2022–2023 “tripledemic” period.

1. Estimated Cumulative Burden (Season to Date)

The CDC’s preliminary models for the current season show a substantial impact on the population:

• Total Illnesses: ~7,500,000 😷

• Medical Visits: ~3,400,000

• Hospitalizations: ~81,000 🏥

• Total Deaths: ~3,100 💔

2. High-Risk Populations & Hospitalization Rates

The burden is not evenly distributed. The A(H3N2) strain is historically associated with more severe outcomes in the elderly and the very young.

• Adults 65+: This group currently has the highest hospitalization rate at 53.2 per 100,000 population. 👴👵

• Children 0–4: This age group follows with 21.1 per 100,000. 👶

• Pediatric Impact: Tragically, 8 pediatric deaths have been confirmed so far this season, with 5 of those occurring in the final week of December alone.

3. Vulnerable Groups ⚠️

Current surveillance indicates that non-Hispanic Black and American Indian/Alaska Native populations are experiencing disproportionately higher hospitalization rates, highlighting ongoing disparities in vaccine access and healthcare utilization.

Prevention & Mitigation Strategies 💉

Despite the “mismatch” of the H3N2 subclade K variant, public health officials stress that vaccination remains the single most effective tool for preventing death and hospitalization.

1. 2025–2026 Vaccine Specifications

• Trivalent Standard: All U.S. vaccines are now trivalent (covering H1N1, H3N2, and B/Victoria). The B/Yamagata lineage has been removed as it is no longer in global circulation.

• Thimerosal-Free Priority: For the first time, the CDC specifically recommends single-dose, thimerosal-free formulations for children and pregnant women. 🤰

• Self-Administration: FluMist (nasal spray) is now available for self-administration by adults (18–49) or caregiver-administration for children (2+), allowing for easier at-home prevention. 👃

2. Effectiveness Expectations ✅

While the vaccine’s ability to prevent mild infection from subclade K is reduced, it remains highly effective at preventing severe disease:

• Adults: Estimated 30–40% effective at preventing hospitalization.

• Children: Estimated 70–75% effective at preventing severe complications.

3. Clinical Management & Treatment 💊

With high levels of resistance to older adamantane drugs, the CDC recommends the following for confirmed or suspected cases:

• Early Antivirals: Prescription drugs like Oseltamivir (Tamiflu) or Baloxavir (Xofluza) should be started within 48 hours of symptom onset, especially for those in high-risk groups. ⏰

• Self-Isolation: Patients should remain home for at least 24 hours after their fever has resolved without the use of fever-reducing medications. 🏠

• Airborne Precautions: Improving indoor air quality through HEPA filtration or increased ventilation is being heavily promoted this season to reduce transmission in schools and offices. 🌬️

Stay Protected with KSP Health 🛡️

At KSP Health, we’re committed to keeping you and your family safe during this challenging influenza season. Our healthcare team is ready to provide comprehensive flu care, including:

Flu Vaccination Services:

2025-2026 trivalent flu vaccines available for all ages
Thimerosal-free formulations for children and pregnant women
FluMist nasal spray option for eligible patients
Same-day appointments available ✅

Flu Testing & Treatment:

Rapid influenza testing with results in minutes
Early antiviral prescriptions (Tamiflu, Xofluza) for high-risk patients
Comprehensive symptom management and monitoring
Telehealth consultations for convenience and safety 💻

High-Risk Patient Care:

Specialized protocols for adults 65+, young children, and immunocompromised individuals
Proactive monitoring and follow-up care
Coordination with specialists when needed

Don’t wait until symptoms worsen. Early intervention is key to preventing severe complications from this year’s aggressive flu variant. Whether you need a flu shot, testing, or treatment, we’re here to help! 💙

📅 Schedule your flu vaccination or visit today:
Book Your Appointment Here

Visit us at KSPHealth.org to learn more about our flu prevention and treatment services.

Stay healthy, stay informed, and stay protected this flu season! 🌟

References: